www.fdanews.com/articles/156715-gsk-muscular-dystrophy-drug-gets-breakthrough-status
GSK Muscular Dystrophy Drug Gets Breakthrough Status
June 28, 2013
The FDA has granted GlaxoSmithKline breakthrough status for its Duchenne muscular dystrophy drug drisapersen.
Reuters
Reuters